KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Debt to Equity (2017 - 2025)

Astrana Health's Debt to Equity history spans 14 years, with the latest figure at $0.06 for Q3 2025.

  • For Q3 2025, Debt to Equity fell 90.17% year-over-year to $0.06; the TTM value through Sep 2025 reached $0.06, down 90.17%, while the annual FY2024 figure was $0.61, 34.31% up from the prior year.
  • Debt to Equity for Q3 2025 was $0.06 at Astrana Health, up from $0.02 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.68 in Q1 2021 and bottomed at $0.0 in Q1 2023.
  • The 5-year median for Debt to Equity is $0.42 (2022), against an average of $0.41.
  • The largest annual shift saw Debt to Equity tumbled 99.71% in 2023 before it surged 52383.98% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.4 in 2021, then decreased by 7.35% to $0.37 in 2022, then grew by 20.47% to $0.45 in 2023, then soared by 34.31% to $0.61 in 2024, then crashed by 90.0% to $0.06 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Debt to Equity are $0.06 (Q3 2025), $0.02 (Q2 2025), and $0.54 (Q1 2025).